As we all brush up on endocrinology to understand Alistair Overeem’s elevated testosterone levels, the UFC is working damage control and trying to salvage their UFC 146 main event.
Overeem was/is scheduled to meet UFC heavyweight champion Junior dos Santos at UFC 146, but was caught with a 14:1 testosterone-to-epitestosterone ratio with a surprise drug test given by the Nevada State Athletic Commission at a pre-fight press conference. The allowable T/E limit for Nevada is 6:1, which is a criticized figure as it’s significantly higher than the 4:1 required by most states and the World Anti-Doping Agency. The average is 1:1.
It’s been widely assumed that Overeem will be pulled from the bout because of his test results, but that may not be the case. The Flying Knee MMA reports that an application for licensure to fight has been filed with the NSAC for Overeem. His hearing with the NSAC is set for April 24th.
Though Overeem had not filed a therapeutic use exemption with the NSAC for testosterone replacement therapy, he was also not licensed with the commission at the time of the random testing (in a confusing episode related to drug testing, he was only granted a temporary license to face Brock Lesnar at UFC 141 in Las Vegas late last year).
Overeem has remained completely silent since the news broke, so far opting not to have the second sample (his B sample) taken by the NSAC tested to refute the results of the original test. The UFC has also kept mostly quiet on the subject.